3ŒŽ28“ú(月)@9:00~11:00@F‰ïê パシフィコ横浜 会è°ã‚»ãƒ³ã‚¿ãƒ¼ã€€3F 311+312 GS03 æ¬¡ä¸–ä»£è‹¥æ‰‹ç ”ç©¶è€…ã®æŒ‘戦ï¼ï½žé›£æ²»æ€§ç–¾æ‚£ã«å¯¾ã™ã‚‹æ–°ãŸãªå‰µè–¬ã‚¹ãƒˆãƒ©ãƒ†ã‚¸ãƒ¼ï½ž The Challenge of Next-Generation Young Pharmacologists~The Strategy of Drug Discovery and Evolution for Intractable Disease~ オーガナイザー:ç¦é‡ 亮ã€å°¾å´Ž å‹é¦™ GS03-1 ã‚»ãƒãƒˆãƒ‹ãƒ³/5-HT3å—容体を標的ã¨ã—ãŸæ¶ˆåŒ–管炎症制御ã¸ã®å¿œç”¨ Therapeutic targeting of serotonin/5-HT3 receptors in gut inflammation ƒVƒ“ƒ|ƒWƒXƒg F ○内海 大知ã€æ¾æœ¬ å¥æ¬¡éƒŽã€å¤©ãƒ¶ç€¬ 紀久åã€å €æ±Ÿ ä¿Šæ²»ã€åŠ è—¤ 伸一 GS03-2 Cyclophosphamide誘起膀胱炎・膀胱痛マウスã«ãŠã‘ã‚‹ç¡«åŒ–æ°´ç´ /Tåž‹Ca2+ãƒãƒ£ãƒãƒ«ç³»ã®å½¹å‰²â€•ä¸‹éƒ¨å°¿è·¯æ©Ÿèƒ½éšœå®³ã«å¯¾ã™ã‚‹æ–°ãŸãªæ²»ç™‚標的分åã¨ã—ã¦ã®å¯èƒ½æ€§â€• The role of hydrogen sulfide/T-type Ca2+ channel pathway in mice with cyclophosphamide-induced cystitis and bladder pain—Possible novel therapeutic targets for lower urinary tract dysfunction— ƒVƒ“ƒ|ƒWƒXƒg F ○尾崎 å‹é¦™ã€åªç”° 真帆ã€å·ç•‘ ç¯¤å² GS03-3 æ–°è¦ç·‘内障治療薬ã¨ã—ã¦ã®ã‚¢ãƒšãƒªãƒ³ã®å¯èƒ½æ€§ Possibility of apelin as the new glaucoma therapeutic agent ƒVƒ“ƒ|ƒWƒXƒg F â—‹ä½é‡Ž 彰英ã€çŸ³ä¸¸ 侑希ã€å±±å®¤ 晶åã€å‰å²¡ é–å•“ã€å‰ç”° 定秋 GS03-4 脳線æ¡ä½“ã¸ã®substance PæŒç¶šæŠ•ä¸Žã«ã‚ˆã‚Šèª˜ç™ºã•ã‚Œã‚‹ç–¼ç—›åˆ¶å¾¡æ©Ÿæ§‹ã®è§£æ˜Ž Elucidation of nociceptive transmission following continuous infusion of substance P into rat striatum ƒVƒ“ƒ|ƒWƒXƒg F â—‹ç¦é‡ 亮ã€ä¸æ‘ 庸è¼ã€æ£®å²¡ 徳光ã€ä»²ç”° 義啓 ŒŸõƒy[ƒW‚É–ß‚é